Oncimmune Holdings (GB:ONC) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Oncimmune Holdings has secured three new contracts valued at £0.34 million, building on its recent commercial success of £2.14 million in contracts over the past three months. The deals with top global pharmaceutical companies highlight Oncimmune’s growing reputation and ability to secure repeat business. As the company progresses, it remains on track to meet its FY2025 revenue targets, showcasing its potential for profitability.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.